Clinical Trial Update: Evaluation of the Long Term Follow up of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease [Phase 2, Phase 3]

View source ↗

Summary

Long-term follow-up data from Phase 2/3 trials evaluating OC-01 nasal spray for dry eye disease have been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• OC-01 Nasal Spray (varenicline)

Snippet

Sponsor: Oyster Point Pharma, Inc. | Conditions: Long Term Follow up Dry Eye Disease | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-11-22